84 related articles for article (PubMed ID: 19646570)
1. Systematic antigenic profiling of hematopoietic antigens on ovarian carcinoma cells identifies membrane proteins for targeted therapy development.
Helpman L; Katz BZ; Safra T; Schreiber L; Levine Z; Nemzer S; Kinar Y; Grisaru D
Am J Obstet Gynecol; 2009 Aug; 201(2):196.e1-7. PubMed ID: 19646570
[TBL] [Abstract][Full Text] [Related]
2. A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17.
Chiriva-Internati M; Grizzi F; Weidanz JA; Ferrari R; Yuefei Y; Velez B; Shearer MH; Lowe DB; Frezza EE; Cobos E; Kast WM; Kennedy RC
J Immunol Methods; 2007 Apr; 321(1-2):86-93. PubMed ID: 17336323
[TBL] [Abstract][Full Text] [Related]
3. Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer.
Aggarwal S; He T; Fitzhugh W; Rosenthal K; Feild B; Heidbrink J; Mesmer D; Ruben SM; Moore PA
Gynecol Oncol; 2009 Dec; 115(3):430-7. PubMed ID: 19800108
[TBL] [Abstract][Full Text] [Related]
4. [Aberrant expression of sperm protein 17 enhances migration of ovarian cancer cell line HO-8910].
Liu Q; Li FQ; Han YL; Wang LK; Hou YY
Zhonghua Nan Ke Xue; 2008 Nov; 14(11):982-6. PubMed ID: 19102497
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric method for determining folate receptor expression on ovarian carcinoma cells.
Forster MD; Ormerod MG; Agarwal R; Kaye SB; Jackman AL
Cytometry A; 2007 Nov; 71(11):945-50. PubMed ID: 17712798
[TBL] [Abstract][Full Text] [Related]
6. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma.
Rouleau C; Curiel M; Weber W; Smale R; Kurtzberg L; Mascarello J; Berger C; Wallar G; Bagley R; Honma N; Hasegawa K; Ishida I; Kataoka S; Thurberg BL; Mehraein K; Horten B; Miller G; Teicher BA
Clin Cancer Res; 2008 Nov; 14(22):7223-36. PubMed ID: 19010839
[TBL] [Abstract][Full Text] [Related]
7. Microarrays of 41 human tumor cell lines for the characterization of new molecular targets: expression patterns of cathepsin B and the transferrin receptor.
Wirth GJ; Schandelmaier K; Smith V; Burger AM; Fiebig HH
Oncology; 2006; 71(1-2):86-94. PubMed ID: 17347587
[TBL] [Abstract][Full Text] [Related]
8. CD200: a putative therapeutic target in cancer.
Moreaux J; Veyrune JL; Reme T; De Vos J; Klein B
Biochem Biophys Res Commun; 2008 Feb; 366(1):117-22. PubMed ID: 18060862
[TBL] [Abstract][Full Text] [Related]
9. CD138/syndecan-1 and SSEA-1 mark distinct populations of developing ciliary epithelium that are regulated differentially by Wnt signal.
Koso H; Iida A; Tabata Y; Baba Y; Satoh S; Taketo MM; Watanabe S
Stem Cells; 2008 Dec; 26(12):3162-71. PubMed ID: 18787210
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for epithelial ovarian cancers.
Mahata P
Genome Inform; 2006; 17(2):184-93. PubMed ID: 17503391
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry of oesophageal mucosal biopsies; epidermal growth factor receptor, and CD15.
Hopwood D; Jankowski J; Milne G; Wormsley KG
J Pathol; 1992 Jul; 167(3):321-6. PubMed ID: 1381435
[TBL] [Abstract][Full Text] [Related]
12. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
[TBL] [Abstract][Full Text] [Related]
13. Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms.
Ohishi Y; Oda Y; Kurihara S; Kaku T; Yasunaga M; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Aug; 40(8):1168-75. PubMed ID: 19368953
[TBL] [Abstract][Full Text] [Related]
14. Diminished CD10, CD13, and CD15 expression in a differentiated granulocyte population in CML.
Cruse JM; Lewis RE; Sanders CM; Webb RN; Beason KL; Lam J; Koehler J
Exp Mol Pathol; 2007 Oct; 83(2):274-6. PubMed ID: 17662271
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemic-type ovarian small cell carcinoma with unique CD34 expression.
Inadome Y; Shibata T; Suzuki K; Tsugata M; Shimabukuro K; Noguchi M
Pathol Int; 2009 Oct; 59(10):766-8. PubMed ID: 19788625
[No Abstract] [Full Text] [Related]
16. Erythrocytic precursor cells show potent shear stress resistant adhesion and home to hematopoietic tissue in vivo.
Hintze C; Ströbele C; Rüster B; Göttig S; Bugert P; Seifried E; Henschler R
Transfusion; 2009 Oct; 49(10):2122-30. PubMed ID: 19500322
[TBL] [Abstract][Full Text] [Related]
17. Expression of surface markers on the human monocytic leukaemia cell line, THP-1, as indicators for the sensitizing potential of chemicals.
An S; Kim S; Huh Y; Lee TR; Kim HK; Park KL; Eun HC
Contact Dermatitis; 2009 Apr; 60(4):185-92. PubMed ID: 19338585
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters.
Dong HP; Holth A; Kleinberg L; Ruud MG; Elstrand MB; Tropé CG; Davidson B; Risberg B
Am J Clin Pathol; 2009 Nov; 132(5):756-62. PubMed ID: 19846818
[TBL] [Abstract][Full Text] [Related]
19. Nuclear cyclin B1 is overexpressed in low-malignant-potential ovarian tumors but not in epithelial ovarian cancer.
Zheng H; Hu W; Deavers MT; Shen DY; Fu S; Li YF; Kavanagh JJ
Am J Obstet Gynecol; 2009 Oct; 201(4):367.e1-6. PubMed ID: 19608149
[TBL] [Abstract][Full Text] [Related]
20. A peculiar pattern of expression of the transferrin receptor (CD71) by reticulocytes in patients given recombinant human erythropoietin (rHuEPO): a novel marker for abuse in sport?
Borrione P; Parisi A; Salvo RA; Spaccamiglio A; Pautasso M; Baraban D; Piccoli GB; Pigozzi F; Angeli A
J Biol Regul Homeost Agents; 2007; 21(3-4):79-88. PubMed ID: 18261259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
